WallStreetZenWallStreetZen

NASDAQ: TXG
10x Genomics Inc Earnings & Revenue

TXG past revenue growth

How has TXG's revenue growth performed historically?
Company
16.64%
Industry
9.88%
Market
19.74%
TXG's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TXG's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TXG's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

TXG earnings and revenue history

Current Revenue
$625.4M
Current Earnings
-$264.3M
Current Profit Margin
-42.3%

TXG Return on Equity

Current Company
-35.3%
Current Industry
6.8%
Current Market
28.2%
TXG's Return on Equity (-35.3%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when TXG announces earnings.

TXG Return on Assets

Current Company
-27.6%
Current Industry
2%
TXG is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

TXG Return on Capital Employed

Current Company
-31.55%
Current Industry
5.6%
TXG has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TXG vs Health Information Service Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
TXG$625.45M-$210.40M-$264.30M+24.04%N/A
PRVA$1.69B$25.81M$18.74M+102.05%-78.56%
PINC$1.34B$246.87M$80.33M+9.25%-38.85%
EVH$2.18B$53.37M-$141.23M+26.00%N/A
BTSGN/AN/AN/AN/AN/A

TXG earnings dates

Next earnings date
Aug 1, 2024

10x Genomics Earnings & Revenue FAQ

What were TXG's earnings last quarter?

On Invalid Date, 10x Genomics (NASDAQ: TXG) reported Q1 2024 earnings per share (EPS) of -$0.50, up 13.64% year over year. Total 10x Genomics earnings for the quarter were -$59.95 million. In the same quarter last year, 10x Genomics's earnings per share (EPS) was -$0.44.

If you're new to stock investing, here's how to buy 10x Genomics stock.

What was TXG's earnings growth in the past year?

As of Q3 2024, 10x Genomics's earnings has grown year over year. 10x Genomics's earnings in the past year totalled -$264.30 million.

What is TXG's earnings date?

10x Genomics's earnings date is Invalid Date. Add TXG to your watchlist to be reminded of TXG's next earnings announcement.

What was TXG's revenue last quarter?

On Invalid Date, 10x Genomics (NASDAQ: TXG) reported Q1 2024 revenue of $141.01 million up 5.01% year over year. In the same quarter last year, 10x Genomics's revenue was $134.29 million.

What was TXG's revenue growth in the past year?

As of Q3 2024, 10x Genomics's revenue has grown 16.64% year over year. This is 6.77 percentage points higher than the US Health Information Services industry revenue growth rate of 9.88%. 10x Genomics's revenue in the past year totalled $625.45 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.